FindTrial
Sign In

New insight of lipiodol on pregnancy outcome in women with recurrent implantation failure undergoing IVF/ICSI: a propensity score–matched study

New insight of lipiodol on pregnancy outcome in women with recurrent implantation failure undergoing IVF/ICSI: a propensity score–matched study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077192
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent implantation failure

Interventions

lipiodol flush group, no flush group:NA

Sponsors

Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Age 20-40 years old; (2) Diagnosed as RIF (embryo implantation failure frequency = 3 times); (3) Both male and female chromosomes are normal;

Exclusion criteria

Exclusion criteria: (1) Excluding patients with recurrent miscarriage; (2) Exclude patients with hydrosalpinx; (3) Excluding patients with reproductive tract abnormalities;

Design outcomes

Primary

MeasureTime frame
live birth rate;—

Secondary

MeasureTime frame
clinical pregnancy rate;miscarriage rate;—

Countries

China

Contacts

Public ContactYang Yihua

Guangxi Reproductive Medical Center, the First Affiliated Hospital of Guangxi Medical University

workyyh@163.com+86 771 535 6816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026